HMGB1 and Acute hepatitis: Other studies have shown that glycyrrhizin can inhibit inflammation and apoptosis in lipopolysaccharide (LPS) induced acute liver injury mice by inhibiting high mobility group protein B1 (HMGB1) via the PI3K/mTOR signaling pathway, suggesting that it could be used as a new treatment strategy for acute hepatitis (143).